BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33934394)

  • 41. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
    He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shelterin and the replisome: at the intersection of telomere repair and replication.
    Cicconi A; Chang S
    Curr Opin Genet Dev; 2020 Feb; 60():77-84. PubMed ID: 32171974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence.
    Li T; Luo Z; Lin S; Li C; Dai S; Wang H; Huang J; Ma W; Songyang Z; Huang Y
    Aging (Albany NY); 2020 Jul; 12(14):14791-14807. PubMed ID: 32687062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer chromosomes going to POT1.
    Chang S
    Nat Genet; 2013 May; 45(5):473-5. PubMed ID: 23619786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RPA and POT1: friends or foes at telomeres?
    Flynn RL; Chang S; Zou L
    Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PTOP interacts with POT1 and regulates its localization to telomeres.
    Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
    Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pot1 and telomere maintenance.
    Baumann P; Price C
    FEBS Lett; 2010 Sep; 584(17):3779-84. PubMed ID: 20493859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Maintenance and expansion of hematopoietic stem cell by POT1].
    Arai F
    Rinsho Ketsueki; 2020; 61(9):1064-1070. PubMed ID: 33162500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer.
    Fujii K; Sasahira T; Moriwaka Y; Oue N; Yasui W; Kuniyasu H
    Int J Mol Med; 2008 May; 21(5):599-604. PubMed ID: 18425352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
    Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
    J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The evolution of metazoan shelterin.
    Myler LR; Kinzig CG; Sasi NK; Zakusilo G; Cai SW; de Lange T
    Genes Dev; 2021 Dec; 35(23-24):1625-1641. PubMed ID: 34764137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CGGBP1 phosphorylation constitutes a telomere-protection signal.
    Singh U; Maturi V; Jones RE; Paulsson Y; Baird DM; Westermark B
    Cell Cycle; 2014; 13(1):96-105. PubMed ID: 24196442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length.
    Miyoshi T; Kanoh J; Saito M; Ishikawa F
    Science; 2008 Jun; 320(5881):1341-4. PubMed ID: 18535244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines.
    Motevalli A; Yasaei H; Virmouni SA; Slijepcevic P; Roberts T
    Breast Cancer Res Treat; 2014 Jun; 145(3):581-91. PubMed ID: 24807106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of deleterious effects of nsSNPs in the POT1 gene: a structural genomics-based approach to understand the mechanism of cancer development.
    Amir M; Kumar V; Mohammad T; Dohare R; Hussain A; Rehman MT; Alam P; Alajmi MF; Islam A; Ahmad F; Hassan MI
    J Cell Biochem; 2019 Jun; 120(6):10281-10294. PubMed ID: 30556179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect.
    Salvati E; Leonetti C; Rizzo A; Scarsella M; Mottolese M; Galati R; Sperduti I; Stevens MF; D'Incalci M; Blasco M; Chiorino G; Bauwens S; Horard B; Gilson E; Stoppacciaro A; Zupi G; Biroccio A
    J Clin Invest; 2007 Nov; 117(11):3236-47. PubMed ID: 17932567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. POT1 as a terminal transducer of TRF1 telomere length control.
    Loayza D; De Lange T
    Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection of Telomeres 1 is required for telomere integrity in the moss Physcomitrella patens.
    Shakirov EV; Perroud PF; Nelson AD; Cannell ME; Quatrano RS; Shippen DE
    Plant Cell; 2010 Jun; 22(6):1838-48. PubMed ID: 20515974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.